Sanofi (SNY) Q3 2022 Earnings Call Transcript

SNY earnings call for the period ending September 30, 2022.

Related Keywords

Japan ,Kenya ,United States ,Tuban ,Shanxi ,China ,Italy ,Udupi ,Hubei ,Spain ,Antero Germine ,David Risinger ,Luisa Hector ,Graham Parry ,Richard Parkes ,Tim Anderson ,Luisa Hector Berenberg ,Joe Walton ,Thomas Triomphe ,Sanofi Pasteur ,Paul Hudson ,Richard Parkes Exane ,Julie Van Ongevalle ,Wimal Kapadia ,Eva Schaefer Jansen ,Olivier Charmeil ,America Merrill Lynch ,Keyur Parekh Goldman Sachs ,Keyur Parekh ,Peter Welford Jefferies ,Sanofi Genzyme ,Richard Vosser Jpmorgan ,Peter Welford ,Jo Walton ,Richard Vosser ,Wimal Kapadia Alliancebernstein ,Hepatic Assessment Committee ,Credit Suisse ,Graham Parry Bank ,Sustainable Markets Initiative ,Global Head Of Research ,Emera ,Brian Lau Wolfe Research Analyst ,Company Analyst ,Barclays ,Bill Sibold ,Jean Baptiste De Chatillon ,Specialty Care ,President Biden ,Inflation Reduction Act ,Bay Fortis ,Scribe Therapeutics ,King Charles ,Vice President Sanofi ,Vice President ,Chewy Bites ,Sub Chews ,Tuban Befor ,Hepatic Assessment ,Global Head ,Maybe Jean Baptiste ,Immunology Day ,Emily Field ,Capital Markets ,North America ,Executive Vice President ,